Trademark Overview
On Tuesday, May 27, 2025, a trademark application was filed for NOVACELL+ with the United States Patent and Trademark Office. The USPTO has given the NOVACELL+ trademark a serial number of 99203389. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 27, 2025. This trademark is owned by Bioxcellerator LLC. The NOVACELL+ trademark is filed in the Pharmaceutical Products category with the following description:
Biologics in the nature of pharmaceutical preparations for the treatment of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine, and for accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for the treatment and prevention of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine, and for accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for combined exosome and stem cell treatments; Pharmaceutical preparations for accelerating healing and improvement of personal health and wellness, namely, exosomes and stem cells; Biologics in the nature of cells for the treatment of chronic conditions and autoimmune diseases, namely, exosomes, extracellular vesicles, and stem cells; Biological preparations for the treatment of chronic conditions and autoimmune diseases, and for accelerating healing and improvemen...
